Viewing StudyNCT06206902



Ignite Creation Date: 2024-05-06 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06206902
Status: RECRUITING
Last Update Posted: 2024-02-23
First Post: 2023-12-18

Brief Title: F01 in the Treatment of RelapsedRefractory Non-hodgkins Lymphoma
Sponsor: Shanghai Simnova Biotechnology CoLtd
Organization: Shanghai Simnova Biotechnology CoLtd

Organization Data

Organization: Shanghai Simnova Biotechnology CoLtd
Class: INDUSTRY
Study ID: SNC 103-CD19CAR NK-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Shanghai Simnova Biotechnology CoLtd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Wuhan Union Hospital China OTHER